Blind spots in the new International Society of Hypertension guidelines: physiologically individualized therapy for resistant hypertension based on renin/aldosterone phenotyping, and amiloride for Liddle phenotype Reply

M.P. Schlaich; C. Borghi; M. Tomaszewski; G.S. Stergiou; A.E. Schutte; T. Unger; 2020 ISH Global Hypertension Practice Guidelines Committee

doi:10.1097/HJH.0000000000002612

Blind spots in the new International Society of Hypertension guidelines: physiologically individualized therapy for resistant hypertension based on renin/aldosterone phenotyping, and amiloride for Liddle phenotype Reply

M.P. Schlaich, C. Borghi, M. Tomaszewski, G.S. Stergiou, A.E. Schutte, T. Unger^*, 2020 ISH Global Hypertension Practice Guidelines Committee

^*Corresponding author for this work

CARIM other

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	2339-2340
Number of pages	2
Journal	Journal of Hypertension
Volume	38
Issue number	11
DOIs	https://doi.org/10.1097/HJH.0000000000002612
Publication status	Published - 1 Nov 2020

Keywords

disorder
DISORDER

Access to Document

10.1097/HJH.0000000000002612

Cite this

Schlaich, M. P., Borghi, C., Tomaszewski, M., Stergiou, G. S., Schutte, A. E., Unger, T., & 2020 ISH Global Hypertension Practice Guidelines Committee (2020). Blind spots in the new International Society of Hypertension guidelines: physiologically individualized therapy for resistant hypertension based on renin/aldosterone phenotyping, and amiloride for Liddle phenotype Reply. Journal of Hypertension, 38(11), 2339-2340. https://doi.org/10.1097/HJH.0000000000002612

@article{9750118742ec482a9107b4f196f38b53,

title = "Blind spots in the new International Society of Hypertension guidelines: physiologically individualized therapy for resistant hypertension based on renin/aldosterone phenotyping, and amiloride for Liddle phenotype Reply",

keywords = "disorder, DISORDER",

author = "M.P. Schlaich and C. Borghi and M. Tomaszewski and G.S. Stergiou and A.E. Schutte and T. Unger and {2020 ISH Global Hypertension Practice Guidelines Committee}",

year = "2020",

month = nov,

day = "1",

doi = "10.1097/HJH.0000000000002612",

language = "English",

volume = "38",

pages = "2339--2340",

journal = "Journal of Hypertension",

issn = "0263-6352",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "11",

}

Schlaich, MP, Borghi, C, Tomaszewski, M, Stergiou, GS, Schutte, AE, Unger, T & 2020 ISH Global Hypertension Practice Guidelines Committee 2020, 'Blind spots in the new International Society of Hypertension guidelines: physiologically individualized therapy for resistant hypertension based on renin/aldosterone phenotyping, and amiloride for Liddle phenotype Reply', Journal of Hypertension, vol. 38, no. 11, pp. 2339-2340. https://doi.org/10.1097/HJH.0000000000002612

Blind spots in the new International Society of Hypertension guidelines: physiologically individualized therapy for resistant hypertension based on renin/aldosterone phenotyping, and amiloride for Liddle phenotype Reply. / Schlaich, M.P.; Borghi, C.; Tomaszewski, M. et al.
In: Journal of Hypertension, Vol. 38, No. 11, 01.11.2020, p. 2339-2340.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Blind spots in the new International Society of Hypertension guidelines: physiologically individualized therapy for resistant hypertension based on renin/aldosterone phenotyping, and amiloride for Liddle phenotype Reply

AU - Schlaich, M.P.

AU - Borghi, C.

AU - Tomaszewski, M.

AU - Stergiou, G.S.

AU - Schutte, A.E.

AU - Unger, T.

AU - 2020 ISH Global Hypertension Practice Guidelines Committee

PY - 2020/11/1

Y1 - 2020/11/1

KW - disorder

KW - DISORDER

U2 - 10.1097/HJH.0000000000002612

DO - 10.1097/HJH.0000000000002612

M3 - Comment/Letter to the editor

C2 - 33027116

SN - 0263-6352

VL - 38

SP - 2339

EP - 2340

JO - Journal of Hypertension

JF - Journal of Hypertension

IS - 11

ER -

Schlaich MP, Borghi C, Tomaszewski M, Stergiou GS, Schutte AE, Unger T et al. Blind spots in the new International Society of Hypertension guidelines: physiologically individualized therapy for resistant hypertension based on renin/aldosterone phenotyping, and amiloride for Liddle phenotype Reply. Journal of Hypertension. 2020 Nov 1;38(11):2339-2340. doi: 10.1097/HJH.0000000000002612